-
Medical Journal Report: Adverse Drug Reactions And Pulmonary Embolism Are Often Difficult For Doctors To Diagnose
These Commonly Missed Diagnoses Are Particularly Relevant To Women Using YAZ, Yasmin, And Ocella, As Well As NuvaRing And Ortho Evra (Posted by Tom Lamb at DrugInjuryWatch.com) The November 9, 2009 issue of the…
-
Diet Drug Meridia Has Possible Cardiovascular Risks, Including Stroke, Heart Attack, And Cardiac Death
FDA Early Communication About Meridia (Sibutramine) Side Effects Issued by Agency In November 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) ________________________________________________________________________________________ UPDATE: Abbott Pulls Meridia in U.S. Amid FDA Safety Concerns (10/8/10, Bloomberg) Abbott…
-
November 2009 Medical Journal Article Describes Large Ongoing Study About Safety Of YAZ
INAS-OC Study: Intended To Evaluate Risk Of Developing Cardiovascular Side Effects For Women Who Use YAZ (DRSP/EE 24d) (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2009 we first wrote about the International Active…
-
Drug Industry Document Archive (DIDA) Adds 15 More Pharma-Related Documents To Collection In November 2009
This Archive Contains Some "Secret" Documents Only Made Public In The Course Of Lawsuits Filed Against Pharmaceutical Companies (Posted by Tom Lamb at DrugInjuryWatch.com) Created and maintained by the University of California at San Francisco…
-
Consumers Union’s Safe Patient Project Forum Webcast: “To Err Is Human, To Delay Is Deadly”
Marks 10th Anniversary Of IOM Study On Medical Errors And Raises Concerns About Lack Of Progress (Posted by Tom Lamb at DrugInjuryWatch.com) The Consumers Union’s Safe Patient Project (formerly Stop Hospital Infections) is holding…